TORONTO, Dec. 8, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”) is pleased to provide an update on the progress of its pharmacy initiatives. On December 7, 2021, Pathway Health announced its third major pharmacy agreement in 2021 with the signing of a Collaboration Agreement with Metro Ontario Pharmacies Limited, […]
The President of telehealth company, Pathway Health recently joined Steve Darling from Proactive Investors to discuss the company’s recent news about the company entering into a Service Agreement with Canntab Therapeutics for the oral delivery of cannabinoids in tablet form. In the interview, Wayne Cockburn discussed the reasoning behind signing the agreement with Canntab, how […]
TORONTO, Dec. 2, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”) is pleased to announce that it has entered into a Service Agreement (the “Agreement”) with Canntab Therapeutics Limited (“PILL”), a Canadian biopharmaceutical company focused on the manufacturing and distribution of a full suite of oral tablet cannabinoid products. “We […]
TORONTO, Nov. 15, 2021 /CNW/ – Pathway Health Corp. (“Pathway” or the “Company“) (TSX-V: PHC), an integrated healthcare company that provides advanced products and services to patients suffering from chronic pain and related conditions, announced today that Pathway’s President Wayne Cockburn will be presenting at the Life Science Investor Day Virtual Conference hosted by TSX. The event will be held […]
TORONTO, Nov. 3, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company“) announces the issuance of 238,095 common shares in the capital of the Company (“Common Shares”) in full satisfaction of an amended and restated convertible promissory note dated January 18, 2021 (the “Note”), subject to final TSX Venture Exchange approval. The […]
TORONTO, Sept. 23, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”) is pleased to announce the appointment of Mr. Jack Schroder as its new Corporate Secretary, subject to final TSX Venture Exchange approval. Mr. Schroder is a senior associate at Dentons Canada LLP and a well-respected corporate securities lawyer with many […]
The TSX Venture Exchange has accepted for filing documentation an asset purchase agreement dated Aug. 31, 2021, between Pathway Health Services Corp. (the purchaser), a wholly owned subsidiary of Pathway Health Corp., O Cannabis We Stand on Guard for Thee Corp. (the vendor), and CannTrust Inc. and Morgan Toombs (collectively, the vendor’s shareholders). Pursuant to […]